<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04196192</url>
  </required_header>
  <id_info>
    <org_study_id>QIP10/12/19HJ</org_study_id>
    <nct_id>NCT04196192</nct_id>
  </id_info>
  <brief_title>Febrile Infants - Diagnostic Assessment and Outcome</brief_title>
  <acronym>FIDO</acronym>
  <official_title>Febrile Infants - Diagnostic Assessment and Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Belfast Health and Social Care Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bristol Royal Hospital for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospitals, Leicester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Barts &amp; The London NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Health Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Hospital for Children Glasgow</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Belfast Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Belfast Health and Social Care Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess how clinicians apply guidance in the assessment of&#xD;
      febrile infants presenting the the Emergency Department. The measurable outcomes are:&#xD;
&#xD;
      Primary Objective Report the rates of serious and invasive bacterial infections in febrile&#xD;
      infants&#xD;
&#xD;
      Secondary Objectives Report on the predictive value of different clinical features for&#xD;
      predicting bacterial infections.&#xD;
&#xD;
      Report on the value of biomarkers for predicting serious and invasive bacterial infections.&#xD;
&#xD;
      Assess the performance of clinical practice guidelines for the assessment of febrile infants.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The assessment of febrile infants is difficult. In the UK and Ireland current guidance&#xD;
      advocates that most children under 3 months of age with a fever undergo a full septic screen&#xD;
      including lumbar puncture and receive parenteral antibiotics. Approaches in the United States&#xD;
      and Europe including the PECARN and StepByStep approach allow for the discharge home of some&#xD;
      low risk young infants.&#xD;
&#xD;
      We intend to assess the current approach to febrile infants and compare that to the available&#xD;
      clinical practice guidelines. We also intend to determine which clinical and/or laboratory&#xD;
      features are most predictive of serious bacterial infection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Actual">May 1, 2021</completion_date>
  <primary_completion_date type="Actual">March 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Invasive bacterial infection</measure>
    <time_frame>seven days</time_frame>
    <description>Invasive Bacterial Infection (non-contaminant) confirmed by culture or molecular diagnostic testing of a sterile site i.e. blood or cerebrospinal fluid (CSF). Staphylococcus epidermidis, Propionibacterium acnes, Streptococcus viridans, or Diphtheroides were considered contaminants.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serious bacterial infections</measure>
    <time_frame>seven days</time_frame>
    <description>Urinary tract infections defined as growth of â‰¥100 000 cfu/mL</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">555</enrollment>
  <condition>Meningitis, Bacterial</condition>
  <condition>Bacterial Infections</condition>
  <condition>Urinary Tract Infections</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>All infants aged 0-90 days (inclusive) undergoing routine assessments for fever without source.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Infants aged 0-90 days (inclusive) with a fever of 38 degrees centigrade or higher recorded&#xD;
        in the Emergency Department between the 31/08/2018 and the 01/09/2019.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any infant aged 0 to 90 days (inclusive) with a fever of 38 degrees centigrade or&#xD;
             higher recorded in the Emergency Department.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Days</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Children's Health Ireland</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Belfast Hospital for Sick Children</name>
      <address>
        <city>Belfast</city>
        <state>Northern Ireland</state>
        <zip>BT126BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bristol Royal Children's Hospital</name>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Hospital for Children Glasgow</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leicester Royal Infirmary</name>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal London Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 10, 2019</study_first_submitted>
  <study_first_submitted_qc>December 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 12, 2019</study_first_posted>
  <last_update_submitted>May 8, 2021</last_update_submitted>
  <last_update_submitted_qc>May 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Belfast Health and Social Care Trust</investigator_affiliation>
    <investigator_full_name>Thomas Waterfield</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Meningitis, Bacterial</mesh_term>
    <mesh_term>Meningitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonymised datasets not containing any personal data will be available after publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

